Related Experiment Video

Updated: Jun 17, 2026

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

Small interfering RNA (siRNA) against the Bcl-2 gene increases apoptosis in a canine melanoma cell line

Yuzuru Watanabe1, Rui Kano, Haruhiko Maruyama

  • 1Department of Pathobiology, Nihon University School of Veterinary Medicine 1866, Kameino, Fujisawa, Kanagawa 252-8510, Japan.

The Journal of Veterinary Medical Science
|December 10, 2009
PubMed

Insights

Small interfering RNA (siRNA) targeting canine Bcl-2 genes effectively reduced Bcl-2 expression in melanoma cells, significantly increasing apoptosis. This highlights Bcl-2 as a potential therapeutic target for canine malignant melanoma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Veterinary Medicine

Background:

  • Canine malignant melanoma is an aggressive tumor.
  • Bcl-2 is a key protein regulating apoptosis.
  • Targeting Bcl-2 may offer a therapeutic strategy for canine melanoma.

Purpose of the Study:

  • To investigate the effect of down-regulating Bcl-2 expression on apoptosis in canine malignant oral melanoma cells.
  • To assess the efficacy of small interfering RNA (siRNA) in targeting canine Bcl-2 genes.
  • To evaluate Bcl-2 as a potential therapeutic target.

Main Methods:

  • Transfection of MCM-N1 cells (canine malignant oral melanoma cell line) with siRNA using cationic liposomes.
  • Quantitative assessment of apoptosis.
  • Measurement of Bcl-2 mRNA and protein expression using RT-PCR and western blot analysis.

Main Results:

  • siRNA targeting canine Bcl-2 genes successfully down-regulated Bcl-2 mRNA and protein expression in MCM-N1 cells.
  • A significant increase in the number of apoptotic cells was observed following Bcl-2 down-regulation.
  • Sequence-specific reduction of Bcl-2 expression was confirmed.

Conclusions:

  • Bcl-2 plays a crucial role in inhibiting apoptosis in canine melanoma.
  • Targeting Bcl-2 with siRNA is a viable approach to induce apoptosis in canine malignant melanoma.
  • Bcl-2 represents a promising therapeutic target for canine malignant melanoma treatment.

More Related Videos

Assessment of Selective mRNA Translation in Mammalian Cells by Polysome Profiling10:00

Assessment of Selective mRNA Translation in Mammalian Cells by Polysome Profiling

Published on: October 28, 2014

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...